ImmunityBio, Inc. IBRX Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s other noncash income (expense)?
- ImmunityBio, Inc. (IBRX) reported other noncash income (expense) of $62K in Q1 2026.
- How has ImmunityBio, Inc.'s other noncash income (expense) changed year-over-year?
- ImmunityBio, Inc.'s other noncash income (expense) decreased by 0.0% year-over-year, from $62K to $62K.
- What is the long-term trend for ImmunityBio, Inc.'s other noncash income (expense)?
- Over 3 years (2022 to 2025), ImmunityBio, Inc.'s other noncash income (expense) has grown at a -72.3% compound annual growth rate (CAGR), from -$11.75M to $250K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.